Info & Opinion
February 19, 2019
With news about big data, Aetna, Covance, GNS, Scrip, Quintiles, PPD, Icon, BioClinica, Merge, Medidata and GSK.
With news about FDA, CTMS, PMG Research, Inclinix, EMA, Hemofarm, Parexel and the Korea Drug Development Fund
David Underwood of Quanticate says some firms are giving short shrift to the basics of clinical trials
With news about Roche, Quintiles, Allscripts, Janssen, SGS, Oracle, TriReme, OpenClinica and FDA
Decision View, a San Francisco firm specializing in advanced patient recruitment algorithms, announced that it has been acquired by IMS Health. Terms were not disclosed. The news release says Decision View helped design and monitor recruitment campaigns for 1,200 trials since the company's inception. "We will enhance clinical trial productivity–transforming the way patient studies are planned and executed,” said IMS senior VP Andrew Kress.
CRF Health, a provider of electronic patient diaries, says that its software now runs on Google's Android phone platform. CRF Health CTO Pekka Keskiivari added: "One of the greatest strengths of our TrialMax suite is that it supports different data collection modalities on the same platform, which can be freely combined in the same study.” Here's a release.
GBI Research is offering a $3,500 report on the contract research organization (CRO) industry. It contends the industry grew at a 12 percent rate from 2009 to 2010, with an estimated rise in revenues from $19.1 to $21.4 billion. The document includes forecasts for major industry trends until 2018, as well as analyses of CRO research activity by geography and phase of trial.
BioSoteria, a drug safety firm, has been acquired by Dohmen, a healthcare-oriented holding company in Milwaukee, Wisconsin. "BioSoteria has been recognized as industry thought leaders as a result of its consulting work in drug safety educational programs, for creating the Pacific Drug Safety Summit, the largest drug safety conference in the Western U.S., and eLadder Safety, the nation’s first comprehensive online training and workshop series for pharmacovigilance and drug safety," the news release states. We cannot discern the unifying principle of the business units under the Dohmen umbrella, but the firm's website is attractive.
Quanticate, a data management-oriented contract research organization (CRO), is adding an office in Bangalore, India. Said Daniel Chapple, executive VP and chief commercial officer: "Our customers will also benefit from even more cost effective offerings, particularly with the large-scale FSP's that we have in place." Here's an earlier ClinPage profile of the firm.
Moffitt Cancer Center, based in Tampa, Florida, says it is using a database and several life science and healthcare programs from Oracle. "Moffitt has automated clinical trial candidate identification, eliminating a manual effort that required months of reviewing paper and electronic data sources to identify the best candidates. Researchers can access information on demand, from their desktops to find de-identified patient cohorts within minutes," the organization noted. Oracle seems to be de-emphasizing the acquired or internally-developed pieces of its clinical trial toolkit and calling greater attention to the synergies between its offerings.